Nexalin Technology (NXL) Return on Equity [ROE] (2022 - 2026)
Nexalin Technology (NXL) reported Return on Equity [ROE] of -408.06% for Q2 2026, down 194.52 percentage points from -213.55% a year earlier and down 156.92 percentage points from the prior quarter.
Powered by 
Analysis
Nexalin Technology (NXL) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Nexalin Technology posted Return on Equity [ROE] of -221.48%, down 0.28 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a three-year change of -121.79 percentage points (FY2022 to FY2025).
- By year, Return on Equity [ROE] came in at -221.19% in FY2024 (-114.15 pp), -107.05% in FY2023 (-7.36 pp) and -99.69% in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q3 2022.
- Year over year, Return on Equity [ROE] gained in three of the last eight quarters, with an average year-over-year change of -33.68 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2025 (a gain of 80.53 percentage points); the low point was Q2 2024 (a drop of 238.09 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -251.15% (Q1 2026), -193.07% (Q4 2025) and -161.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.25 Bn | 220.40 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 167.33 Bn | 138.41 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 148.83 Bn | 132.65 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 142.00 Bn | 121.55 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.70 Bn | 76.57 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 104.72 Bn | 90.84 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 62.66 Bn | 57.67 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.13 Bn | 33.24 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.51 Bn | 45.66 Bn | 2.32 Bn | 3.88% |
| 10 | Nexalin Technology | 5.54 Mn | -6.25 Mn | 8,897.00 | -408.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -408.06% |
| Mar 31, 2026 | -251.15% |
| Dec 31, 2025 | -193.07% |
| Sep 30, 2025 | -161.73% |
| Jun 30, 2025 | -213.55% |
| Mar 31, 2025 | -285.01% |
| Dec 31, 2024 | -176.33% |
| Sep 30, 2024 | -176.24% |
| Jun 30, 2024 | -294.07% |
| Mar 31, 2024 | -178.81% |
| Dec 31, 2023 | -144.30% |
| Sep 30, 2023 | -127.39% |
| Jun 30, 2023 | -55.98% |
| Mar 31, 2023 | -40.79% |
| Dec 31, 2022 | -29.20% |
| Sep 30, 2022 | -77.14% |
API Access
Nexalin Technology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();